In the SURPASS clinical trial program, which enrolled over 6,000 participants with type 2 diabetes, the most common side effects included nausea (reported in 12% to 29% of patients), diarrhea (13% to 16%), vomiting (5% to 10%), constipation (6% to 7%), and abdominal discomfort
Ozempic label provides placebo-controlled adverse reaction rates for common events (5%) dominated by GI symptoms (dose-related increases in nausea, vomiting, diarrhoea, constipation/abdominal pain)
The Food and Drug Administration announced an official shortage of the active ingredients in these drugs in 2022, but on Oct
The clinical evidence For people with diabetes: Research indicates that semaglutide can lower the likelihood of major heart events, including strokes and heart attacks, by approximately 20% in overweight or obese individuals without a diabetes diagnosis
Although some studies pointed out that vitamin D supplementation ameliorated triglycerides and LDL cholesterol levels (33, 34), several high-quality studies (3537) reported no significant lipid modification of 25(OH)D